By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
While CTRE's record investments and growth are praised, the sustainability of its 8.9% yield and potential dilution from equity issuance are key concerns.
Risk: Potential dilution and higher borrowing costs due to sustained high growth and yield maintenance.
Opportunity: Continued successful execution across diverse geographies and asset types.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Image source: The Motley Fool.
Friday, Aug. 7, 2026 at 11:00 a.m. ET
Operator: Hello, everyone. Thank you for joining us, and welcome to the CareTrust Second Quarter Earnings Call. [Operator Instructions] I will now hand the conference over to Lauren Beale, Chief Accounting Officer. Lauren, please go ahead.
Lauren Beale: Thank you, and welcome to CareTrust REIT's Second Quarter 2026 Earnings Call. Today, we will make forward-looking statements based on management's current expectations, including statements regarding future financial performance, dividends, acquisitions, investments, financing plans, business strategies and growth prospects. These forward-looking statements are subject to risks and uncertainties that could cause actual results to materially differ from our expectations. These risks are discussed in CareTrust REIT's most recent Form 10-Q filing with the SEC. We do not undertake a duty to update or revise these statements, except as required by law. During the call, the company will reference non-GAAP metrics such as EBITDA, FFO and FAD.
A reconciliation of these measures to the most comparable GAAP financial measures is available in our earnings press release and Q2 2026 financial supplement, which are available on the Investor Relations section of CareTrust's website at www.caretrustreit.com. A replay of this call will also be available on the website for a limited period. On the call this morning are David Sedgwick, President and Chief Executive Officer; Derek Bunker, Chief Financial Officer; and James Callister, Chief Investment Officer. I'll now turn the call over to Dave Sedgwick, CareTrust REIT's President and CEO. Dave?
David Sedgwick: Thank you, Lauren, and good morning, everybody. Thank you for joining us. The CareTrust flywheel cranked up a few years ago when we hit around 7x our lifetime annual average of investments in 2024 and again in 2025. The team shows no signs of slowing. In fact, the opposite is true. After 2 back-to-back record-setting years, we are again on pace to deliver in a big way for our operators and shareholders. Last quarter was the single largest investment quarter in our company's history, excluding M&A activity, with approximately $900 million of investments at a blended yield of 8.9%.
James, Kyle, Joe, Tri, Josh, JP, Nick, Martin, and Killian, that's the dream team right there responsible for a year's worth of investments in 1 quarter. I'm so proud of them and proud of the entire CareTrust team across the board: accounting, asset management, finance, tax, legal, data, operations. Everyone is rowing hard together to make this year a three-peat of record performance. Q2 results achieved record investments in the quarter, record revenues, record FFO per share and a healthy raise to guidance, built on a foundation of record operator lease coverage and operator quality care measures. Let me expand on that foundation just a little bit.
We are stoked to see our operator quality care measures exceed the industry averages for overall star ratings, health inspections, quality measures, successful discharges and readmission rates. Let me repeat that. Our operators outperform industry averages for overall star ratings, health inspections, quality measures, successful discharges and readmission rates after they've had a chance to manage these buildings for at least 4 years. In my 2025 annual report letter, I discussed how mission-critical it is for us to lease our properties to high-quality operators and how we view the relationship between them and the value of our real estate investments.
A quality operator is one who is driven by a mission, focuses their resources first on becoming the employer of choice and through that, becomes the quality care provider of choice in their market. Only after achieving sustained quality care outcomes can a provider and the real estate they operate achieve sustainable financial stability. We have seen this formula for success prove out over the last 25 years. A CareTrust operator is one who harmonizes mission-driven culture with the clinical and financial sophistication to adapt to an ever-changing environment. We apply those first principles to skilled nursing and senior housing alike. We invest for the long term.
The price we pay and the operator we choose are intended to result in long-term quality care and, as a result, compounding value creation. That solid operator foundation and orientation allows us to grow in a sustainable and accelerated way across our 3 growth engines. Year-to-date, we have already closed on approximately $1.5 billion. And looking forward, the pipeline continues to reload and deal flow continues to be active and interesting across skilled nursing, care homes and SHOP, both in the U.S. and the U.K.
With the balance sheet as strong as it is, the team is stronger than ever before and the opportunity set expanded and great relationships with partners and new and existing high-quality operators, there has simply never been a more exciting time for CareTrust. With that, I'll hand it off to James for a report on investment activity and the acquisition landscape. James?
James Callister: Thanks, Dave. Good morning, everyone. During the second quarter, we closed on investments totaling approximately $900 million at a blended stabilized yield of 8.9%. That capital was deployed across the full breadth of the platform, U.S. skilled nursing sale leasebacks with quality operators in multiple geographies, the continued expansion of our U.K. Care Homes platform, sourced and executed by our London-based team, further growth in our SHOP portfolio and relationship-driven real estate loans, primarily as skilled nursing operators closed either alongside asset acquisitions or in anticipation of them. And as Dave noted, we haven't slowed down since the quarter ended. Since June 30, we've closed on an additional approximately $308 million at a blended stabilized yield of approximately 7.8%.
Headlining that activity was a 16-property U.K. Care Homes portfolio net leased to a new operator relationship for CareTrust, joined by a two-community $65 million addition to our SHOP platform. Taken together, our 2026 investments now stand at approximately $1.5 billion year-to-date. Breaking that down, roughly $735 million in U.S. triple net skilled nursing and seniors housing, approximately $397 million in U.K. Care Homes, approximately $240 million in loans, and approximately $81 million in SHOP. Turning to what's ahead. The pipeline sits at approximately $540 million, roughly 2/3 skilled nursing and 1/3 loans to strategic partners plus U.K. Care Homes. It's a healthy mix, some singles and doubles alongside mid- to large portfolio opportunities.
You'll note the immediate pipe doesn't include SHOP. That's really just a function of timing and discipline. The team continues to deepen relationships, including with high-performing operators, and we are confident these relationships will drive attractive on- and off-market opportunities that we expect to convert in future quarters and give us a long runway to scale that portfolio in both the U.S. and the U.K. And, our usual reminder on methodology, the quoted pipe includes only deals we have a reasonable level of confidence we can lock up and close within the next 12 months, and it typically excludes larger portfolios still under review.
Stepping back for a moment, what gives us real confidence is that all 3 of our growth engines are producing. In skilled nursing, deal flow remains deep and steady with proprietary opportunities generated through long-standing relationships. In SHOP, even amid stiff competition and compressing cap rates, we're pursuing the right assets with the right operators and see a long runway to scale that portfolio in the quarters and years ahead. And in the U.K., our London-based team has widened our aperture considerably, new operators, new sources of deal flow and a pipeline that keeps building. Across all 3, the team continues to surface attractive opportunities to deploy capital, and we like our position in each of these markets.
That growth will stay grounded in the same fundamentals that have served us well, disciplined underwriting, durable operator partnerships, and a creative collaborative approach to structuring. With that, I'll hand it to Derek to walk through the quarter's financial results.
Derek Bunker: Thank you, James. For the quarter, normalized FFO increased 44% over the prior year quarter to $119.7 million, and normalized FAD increased 43% to $118.5 million. On a per share basis, normalized FFO was $0.51, an increase of approximately 19% over the prior year quarter. And normalized FAD was also $0.51, an increase of approximately 19% over the same period. In the second quarter, we raised approximately $364 million of gross proceeds from the settlement of outstanding equity forward contracts to fund investment activity in the quarter. Also in the quarter, we sold 14.4 million shares under forward equity contracts, raising $580.5 million of gross proceeds at a weighted average price of $40.23.
And since quarter end, we sold another 2.2 million shares on a forward basis for gross proceeds of $90.6 million at a weighted average price per share of $41.46. As of today, we have approximately 16.6 million shares remaining unsettled under forward sale agreements, representing approximately $671.4 million in gross proceeds available to fund future investment activity. In yesterday's earnings press release, we raised our full year 2026 guidance, reflecting our year-to-date investment activity, including the volume we've closed since quarter end. We're now projecting normalized FFO per share of $2.03 to $2.06 and normalized FAD per share of $2.01 to $2.04.
At the midpoint, that represents growth of 16.2% in normalized FFO per share and approximately 15.1% in normalized FAD per share compared to full year 2025 results. Our updated guidance is based on a weighted average diluted share count of 233 million shares and includes the following key assumptions: First, no new investments, loans, or dispositions beyond those made year-to-date; second, no new debt or equity issuances beyond those made year-to-date; third, 2.5% inflation-based rent escalators under our long-term triple net leases; fourth, $147 million of loans to be repaid throughout the year, of which approximately $104 million has been received so far to date; and fifth, no material change in the GBP to USD spot exchange rate.
Additional guidance measures are detailed in the press release yesterday. Lastly, our liquidity continues to remain strong at approximately $1.4 billion as of today, including approximately $90 million of cash on hand, $605 million of availability under our $1.2 billion revolving credit facility and approximately $671 million of unsettled equity forward contracts. In addition, we have roughly $785.8 million of capacity available under our ATM program. Net debt to annualized normalized run rate EBITDA was 1.0x at quarter end, well below our long-term target range, and our fixed charge coverage ratio was 9.9x. We continue to have no scheduled debt maturities prior to 2028.
With continued momentum and a reloaded investment pipeline, we have ample dry powder and multiple levers across our capital toolkit to keep funding our recent pace of investment activity. And with that, I'll turn it back to Dave.
David Sedgwick: Thank you, Derek, and thank you, James, and thank you, everybody. We're really grateful for everybody's interest and support. As I hope you can tell, we are super bullish on the CareTrust story and not just what we've achieved, but where we are headed. And with that, I would be happy to answer any of the questions that you might have at this time.
Operator: [Operator Instructions] Your first question comes from John Kilichowski with Wells Fargo.
William John Kilichowski: James, maybe if I could start with you. You gave some helpful color in the opening remarks, especially about building out the SHOP pipeline and it not being mentioned in the -- or SHOP not being mentioned in the current pipeline. Could you talk a little bit more about building those relationships with operators and how that will eventually translate into volumes and how we should think about the cadence of that?
James Callister: Yes, sure. I mean, I think that it's hard to predict the cadence, John. You're never really sure what's going to hit the market or what off-market is going to come. But I think that building relationships with these operators and managers, finding the ones you can use in different regions of the country or have proven track records there that have maybe experiences with other publics and their reporting and back office just really allows you to more quickly pursue transactions that come up. It opens up the off-market pipeline as you develop relationships with them.
And really, as you really start to develop frameworks with them of what your deal with them would look like, the terms on which you do it. And you get really all that kind of prebaked so you can react quickly when the right deal in the right area comes up for you to work with that particular operator or manager. And I think the team has done a great job of developing a lot of those relationships and being ready really to continue and ramp up pursuing acquisitions in different parts of the country.
William John Kilichowski: And then would you also mind talking about the portfolio deals outside of the quoted pipeline? Maybe you don't want to speak to specific deals, but can you talk about the composition of where you're seeing those opportunities? Or is it more SNF tilted? Are there SHOP portfolios out there that you're currently evaluating? I'm just kind of curious what the composition looks like more than anything.
James Callister: Yes. I mean there's a few portfolios tinkering around out there. I would say there's 1 or 2 SHOP portfolios that are larger out there that we're reviewing to see how attractive they are and whether we want to pursue them. There's also, I'd say, the same for SNF and 1 or 2 in the U.K. as well. So there's always seemingly a couple of them floating around, but there are a couple of shops out there that we're looking at, but we'll see if they're really worth us pursuing or if we think that there's traction there.
Operator: Your next question comes from Austin Wurschmidt with KeyBanc Capital Markets.
Austin Wurschmidt: With respect to the Care Home portfolio investment in August, I think this might be one of the largest purchase
Four leading AI models discuss this article
"CTRE’s combination of 8.9% yields, sub-1.0x leverage, and superior operator quality metrics positions it for continued 15%+ FFO/share growth with limited near-term capital-market risk."
CTRE reported a record $900M investment quarter (blended 8.9% yield) plus $308M post-quarter, driving YTD 2026 deployments to $1.5B. Normalized FFO/share rose 19% YoY to $0.51; full-year guidance raised to $2.03–$2.06 (16.2% growth). Leverage remains pristine at 1.0x net debt/EBITDA with $1.4B liquidity. Operator quality metrics now exceed industry averages after 4+ years, supporting the long-term flywheel narrative across SNF, SHOP, and UK care homes. The equity ATM/forward program has funded growth without balance-sheet strain.
The article glosses over execution risk on $540M pipeline (especially larger portfolios), potential cap-rate compression in competitive SHOP, currency/UK regulatory volatility, and the fact that guidance explicitly assumes zero incremental investments—meaning any shortfall versus the torrid pace would force a cut.
"CTRE’s ultra-low leverage and diversified growth engines position it to sustain double-digit FFO growth, provided they maintain their disciplined underwriting amidst an accelerating acquisition pace."
CareTrust REIT (CTRE) is executing a high-velocity capital deployment strategy that is currently firing on all cylinders. With a 19% year-over-year FFO per share growth and a robust $1.4 billion liquidity position, the company is effectively leveraging its balance sheet to scale across three distinct engines: U.S. skilled nursing, U.K. care homes, and SHOP. The 1.0x net debt-to-EBITDA ratio is exceptionally conservative for a REIT, providing significant runway for further accretive acquisitions. Management’s focus on operator quality as a proxy for long-term lease stability is a sound fundamental approach, though the aggressive pace of equity issuance via forward contracts warrants close monitoring to ensure per-share accretion remains durable.
The rapid reliance on $671 million in unsettled equity forward contracts suggests a high cost of capital that could dilute future earnings if acquisition yields compress further or if the U.K. expansion faces unforeseen regulatory or currency headwinds.
"CTRE has shifted from constrained capital deployment to genuine scale (44% FFO growth, record investments), but the thesis hinges entirely on whether 8.9% yields hold as the portfolio seasons and whether the $540M pipeline can sustain current momentum without forcing dilutive equity raises."
CTRE is executing at scale—$1.5B YTD investments, 44% FFO growth, 8.9% blended yields, and net debt at 1.0x EBITDA signal disciplined capital deployment. The three-engine model (U.S. SNF, U.K. Care Homes, SHOP) is firing, and management's operator quality metrics (outperforming industry averages post-4 years) suggest durable cash flows. However, the $540M pipeline represents only ~4 months of recent run-rate, and forward equity contracts ($671M unsettled) create dilution risk if CTRE stock underperforms. Guidance assumes zero new issuances beyond YTD, which may constrain future growth if deal flow accelerates.
The 8.9% yield on $900M deployed in Q2 is attractive only if operators maintain coverage ratios—but management's own emphasis on operator quality suggests prior underwriting failures exist. Rising to $1.5B YTD at these yields requires either cap-rate compression (bad for future acquisitions) or operator stress (bad for dividends).
"CTRE's diversified growth engines and strong liquidity should support upside, but execution risk and macro/regulatory headwinds could cap multiple expansion."
CTRE's Q2 highlights a cash-flow flywheel: $1.5B of investments year-to-date at a blended 8.9% yield, normalized FFO/FAD up ~19% YoY, and a strong liquidity position (~$1.4B) with no near-term debt maturities. The trio of growth engines (US SNF/senior housing, SHOP, and UK care homes) plus a reloaded pipeline imply durable earnings power and potential multiple expansion, aided by equity forward funding flexibility. Raised 2026 guidance reinforces confidence. However, the bull case hinges on execution across diverse geographies and asset types, plus macro headwinds that could compress rents, cap rates, or escalate regulatory/currency risk in the UK.
The upside may be overstated if SHOP and UK bets hit regulatory/currency headwinds, or if operator concentration and market cycles erode spreads; equity dilution from forward-sale programs could cap returns when markets wobble.
"Strong operator metrics undermine the 'stress or compression' binary; hidden risk is post-deployment cost-of-capital creep."
Claude's claim that the 8.9% yield requires either cap-rate compression or operator stress is backwards. The record $900M quarter at that yield, paired with operator metrics now beating industry averages, shows underwriting improvement—not prior failures. The real unmentioned risk is that sustained 19% FFO growth at 1.0x leverage could force credit-rating migration and higher future borrowing costs once liquidity is deployed.
"The stability of 8.9% yields during aggressive expansion suggests CTRE is taking on higher operational risk rather than simply improving underwriting."
Grok, your critique of Claude misses the fundamental math of REIT capital allocation. Sustaining an 8.9% yield while scaling at this velocity isn't just 'underwriting improvement'—it implies CTRE is moving down the credit curve to find yield. As they exhaust the low-hanging fruit in the SNF space, the shift toward UK care homes and SHOP introduces operational complexity that rarely scales linearly. If operator quality truly exceeds industry averages, they should be seeing cap-rate compression, not stable 8.9% yields.
"Sustained 8.9% yields + guidance's zero-issuance assumption = hidden growth ceiling, not underwriting strength."
Gemini's 'moving down the credit curve' framing is more precise than Grok's dismissal. But both miss the operative constraint: CTRE's guidance assumes zero incremental equity issuance beyond YTD. If 8.9% yields persist while the $540M pipeline deploys, management faces a choice—dilute further or slow growth. The market hasn't priced that binary yet.
"CTRE’s 8.9% yield sustainability hinges on cap-rate compression or fresh equity, given unsettled forwards and a growing pipeline."
Challenging Grok’s takeaway: 8.9% yield sustainability may require cap-rate compression or ongoing equity issuances, given CTRE’s $671M unsettled forwards and a $540M pipeline in four months. As the pipeline grows, the business relies on multiple expansion or further dilutive equity to keep per-share growth intact, a path exposed to UK/currency headwinds and SHOP cyclicality. The core risk isn’t just execution—it’s funding discipline and how long the market tolerates dilution.
While CTRE's record investments and growth are praised, the sustainability of its 8.9% yield and potential dilution from equity issuance are key concerns.
Continued successful execution across diverse geographies and asset types.
Potential dilution and higher borrowing costs due to sustained high growth and yield maintenance.